Complited the Clinical trial performed with FABRE laboratory.
Results published in the prestigious journal AACR.
These clinical trials started in early 2013, focusing on the efficacy of F14512, a new anti-cancer treatment.
The encouraging results of this study, showed strong evidence of the drug’s efficacy, also revealed the drug’s potential to fight human lymphoma.
Download the publication